Evidence map›Paper›PMID 11593423›Full record

ArticleOncogene2001

Role of LXCXE motif-dependent interactions in the activity of the retinoblastoma protein.

H M Chan, L Smith, N B La Thangue

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 76 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Aryl Hydrocarbon Receptor: From Homeostasis to Tumor Progression.Frontiers in cell and developmental biology · 2022
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Skin Tumors Rb(eing) Uncovered.Frontiers in oncology · 2013
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

H M ChanDivision of Biochemistry and Molecular Biology, Davidson Building, University of Glasgow, Glasgow, G12 8QQ, UK.
L Smith
N B La Thangue
University of Glasgow · GB

Funding

Medical Research Council G9400953
6 · The paper itself

Abstract

Cell cycle control by pRb requires the integrity of the pocket domain, which is a region necessary for interactions with a variety of proteins, including E2F and LXCXE-motif containing proteins. Through knowledge of the crystal structure of pRb we have prepared a panel of pRb mutant derivatives in which a cluster of lysine residues that demark the LXCXE peptide binding domain were systematically mutated. One of the mutant derivatives, Rb6A, exhibits significantly reduced LXCXE-dependent interactions with HPV E7, cyclinD1 and HDAC2, but retained LXCXE-independent binding to E2F. Consistent with these results, Rb6A could down-regulate E2F-1-dependent activation of different E2F responsive promoters, but was compromised in Rb-dependent repression. Most importantly, Rb6A retained wild-type growth arrest activity, and colony forming activity similar to wild-type pRb. It is compatible with these results that directly targeting HDAC2 to E2F responsive promoters as an E2F/HDAC hybrid protein failed to effect cell cycle arrest. These results suggest that LXCXE-dependent interactions are not essential for pRb to exert growth arrest.

Indexed as

Cell Cycle ProteinsDNA-Binding ProteinsRepressor ProteinsAmino Acid MotifsAmino Acid SequenceCell CycleCell DivisionCyclin D1DNA Mutational AnalysisDown-RegulationE2F1 Transcription FactorE2F Transcription FactorsEpitopesFlow CytometryGlutathione TransferaseHeLa CellsCell Cycle ProteinsCyclin D1DNA-Binding ProteinsE2F1 protein, humanE2F1 Transcription FactorE2F Transcription FactorsEpitopesGlutathione TransferaseHistone Deacetylase 2Histone DeacetylasesLysinePeptidesProto-Oncogene Proteins c-mycRecombinant Fusion ProteinsRepressor ProteinsRetinoblastoma ProteinTranscription Factors

Identifiers

PMID11593423
OpenAlexW2064241321

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.